Pharmacokinetics of metformin in pediatric type 2 diabetic and healthy adult subjects.

被引：9
|
作者：
Gao, X
Christensen, M
Burghen, GA
Velasquez-Mieyer, P
Moore, KT
Donahue, SR
Reeves, RA
Turner, KC
机构：
[1] Bristol Myers Squibb Co, Pharmaceut Res Inst, Princeton, NJ 08543 USA
[2] Univ Tennessee, Knoxville, TN 37996 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2003年 / 73卷 / 02期
关键词：
D O I：
10.1016/S0009-9236(03)90526-1
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P46 / P46
页数：1
相关论文
共 50 条
  • [31] PHARMACOKINETICS OF UPADACITINIB IN HEALTHY JAPANESE AND CHINESE SUBJECTS AND COMPARABILITY TO WESTERN SUBJECTS.
    Mohamed, M-E. F.
    Camp, H. S.
    Jungerwirth, S.
    Othman, A. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 : S80 - S80
  • [32] Pharmacodynamics and pharmacokinetics of ancrod given as a single 12-hour infusion in healthy, adult subjects.
    Johnson, F
    Velagapudi, R
    Hornberger, W
    Weston, I
    Lee, J
    Faulkner, R
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 208 - 208
  • [33] PHARMACOKINETICS OF GLICLAZIDE IN HEALTHY AND DIABETIC SUBJECTS
    KOBAYASHI, K
    KIMURA, M
    SAKOGUCHI, T
    HASE, A
    MATSUOKA, A
    KANEKO, S
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1984, 73 (12) : 1684 - 1686
  • [34] The population pharmacokinetics (PK) of torcetrapib (TOR) in adult subjects.
    Agoram, B. M.
    Milligan, P. A.
    van der Graaf, P. H.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S63 - S63
  • [35] Association of leptin with nephropathy and retinopathy in Type 2 diabetic subjects.
    Ikram, Z
    Shahani, S
    Mahtab, H
    Kibriya, MG
    DIABETOLOGIA, 2003, 46 : A397 - A397
  • [36] VO2/PO Relationship In Type 2 Diabetic Subjects.
    Spigolon, Giorgia
    Fontana, Federico Y.
    Bacchi, Elisabetta
    Moghetti, Paolo
    Pogliaghi, Silvia
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2016, 48 (05): : 607 - 607
  • [37] The pharmacokinetics and pharmacodynamics of prasugrel in healthy Chinese, Japanese, and Korean subjects compared with healthy Caucasian subjects.
    Small, D. S.
    Kothare, P. A.
    Yuen, E. S.
    Li, Y. G.
    Winters, K. J.
    Farid, N. A.
    Ni, L.
    Salazar, D. E.
    Payne, C. D.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S56 - S57
  • [38] Effect of Ondansetron on Metformin Pharmacokinetics and Response in Healthy Subjects
    Li, Qing
    Yang, Hong
    Guo, Dong
    Zhang, Taolan
    Polli, James E.
    Zhou, Honghao
    Shu, Yan
    DRUG METABOLISM AND DISPOSITION, 2016, 44 (04) : 489 - 494
  • [39] Pharmacokinetics, Safety, and Tolerability of Metformin in Healthy Elderly Subjects
    Jang, Kyungho
    Chung, Hyewon
    Yoon, Jang-soo
    Moon, Seol-Joo
    Yoon, Seo Hyun
    Yu, Kyung-Sang
    Kim, Kwangil
    Chung, Jae-Yong
    JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (09): : 1104 - 1110
  • [40] Effect of voglibose on the pharmacokinetics of metformin in healthy Korean subjects
    Kim, Ho-Sook
    Oh, Minkyung
    Kim, Eun Ji
    Song, Geun Seog
    Ghim, Jong-Lyul
    Shon, Ji-Hong
    Kim, Dong-Hyun
    Shin, Jae-Gook
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2014, 52 (11) : 1005 - 1011
12345